Results 21 to 30 of about 12,566 (192)

Pragmatic study of orlistat 60 mg on abdominal obesity [PDF]

open access: yes, 2011
Background/Objectives: It is well established that combining a reduced calorie, low-fat diet with the lipase inhibitor orlistat results in significantly greater weight loss than placebo plus diet.
Frost, G.S.   +25 more
core   +1 more source

Lipase inhibition attenuates the acute inhibitory effects of oral fat on food intake in healthy subjects [PDF]

open access: yes, 2003
The lipase inhibitor, orlistat, is used in the treatment of obesity and reduces fat absorption by about 30%. However, the mean weight loss induced by orlistat is less than expected for the degree of fat malabsorption.
O'Donovan, D.   +3 more
core   +1 more source

Atorvastatin versus tetrahydrolipstatin in male patients with dyslipidemia: A systematic review and meta-analysis [PDF]

open access: yesJournal of Pharmacy & Pharmacognosy Research
Context: Atorvastatin is typically used in the treatment of dyslipidemia. However, the interest in using anti-obesity medications such as orlistat has grown rapidly as obesity is one of the variables associated with dyslipidemia.
Nur Aini Hasan   +4 more
doaj   +1 more source

Acute Oxalate Nephropathy Associated with Orlistat: A Case Report with a Review of the Literature

open access: yesCase Reports in Nephrology, 2013
Orlistat is a gastrointestinal lipase inhibitor used for weight reduction in obese individuals. Enteric hyperoxaluria caused by orlistat leads to oxalate absorption. Acute oxalate nephropathy is a rare complication of treatment with orlistat.
Dhara Chaudhari   +3 more
doaj   +1 more source

Toxic Effects of Orlistat and Green Tea Extract on Testes of Adult Albino Rats:(Comparative Study) [PDF]

open access: yesZagazig Journal of Forensic Medicine and Toxicology, 2022
Background: Obesity is a serious medical health problem in the world. Orlistat drug and green tea herb have an important anti-obesity effect. Aim of the work: This study evaluated the chronic toxic effects of orlistat and green tea extract on testes of ...
Laila Sabik   +3 more
doaj   +1 more source

Acute Pancreatitis Following Orlistat Therapy: Report of Two Cases [PDF]

open access: yes, 2015
Context Orlistat is a pancreatic lipase inhibitor licensed for the treatment of obesity. As obesity rates increase and non-prescription dispensing of orlistat increases, an awareness of its adverse effects is of crucial importance as complications arise ...
Mahmud, Sajid   +3 more
core   +1 more source

Histological and Biochemical Evaluation of Vitamin C’s Protective Role Against Orlistat-Induced Oxidative Stress and Inflammation in Rat Salivary Glands [PDF]

open access: yesAlexandria Dental Journal
Background: Orlistat is lipophilic drug used for obesity treatment. Vitamin C is soluble in water with antioxidant qualities, reducing oxidative stress in salivary glands.Objective: To evaluate the protective effects of Vitamin C on the salivary glands ...
Eman M. Salem   +4 more
doaj   +1 more source

Elevated endotoxin levels in non-alcoholic fatty liver disease [PDF]

open access: yes, 2010
Background: Emerging data indicate that gut-derived endotoxin may contribute to low-grade systemic inflammation in insulin resistant states. This study aimed to examine the importance of serum endotoxin and inflammatory markers in non-alcoholic fatty ...
Ashour, E.   +70 more
core   +1 more source

Effect of orlistat and aquatic extract of Rosmarinus officinalis leaves in histopathological changes in kidney of albino rat [PDF]

open access: yesIraqi Journal of Veterinary Sciences, 2022
This study investigated the effects of orlistat and rosemary extract on kidney tissue when combined with a high-fat diet, as well as the association between these treatments and body weight, blood lipid profile, and oxidative stress status in male rats ...
Alya A. Al-Safo, Liqaa H. AlDulaimi
doaj   +1 more source

Effect of orlistat on liver fat content in patients with nonalcoholic fatty liver disease with obesity: assessment using magnetic resonance imaging-derived proton density fat fraction

open access: yesTherapeutic Advances in Gastroenterology, 2019
Background: The liver effect of orlistat as a weight control treatment in patients with nonalcoholic fatty liver disease (NAFLD) with obesity remains undetermined.
Junzhao Ye   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy